15 November, 2017: The Conversation features critical analysis from Pat Ranald, Deborah Gleeson, Belinda Townsend and others about what has and hasn’t changed in the TPP11 after the ministerial meetings last week. See also Peter Martin's article in Fairfax media.
Media Release November 11, 2017: “TPP 11 leaders meeting in Da Nang Vietnam have agreed on some elements of a possible deal without the US, but have not succeeded in their aim of finalising the text. The talks have only been salvaged by an agreement to rename the deal, suspend some of its most controversial clauses and to have further talks over several months on issues raised by Canada and other governments,” AFTINET Convener Dr Patricia Ranald said today.
November 9, 2017: A new paper by leading health experts published in the Australian Health Review and summarised in Fairfax news and The Conversation has found that the Trans-Pacific Partnership agreement could add up to $367 million to the cost of the Pharmaceutical Benefits Scheme if increases in data protection monopolies for biologic medicines proposed in the original TPP text are implemented.
November 7, 2017: Bernard Keane writes in Crikey that Malcom Turnbull should follow the lead of New Zealand and even the US NAFTA negotiators and ditch ISDS. in the TPP 11.
November 6, 2017 “The Australian Government should oppose foreign investor rights to sue governments in the talks attempting to resurrect the TPP without the US later this week,” AFTINET Convener Dr Patricia Ranald said today.
The talks will take place in da Nang, Vietnam on November 8-9, ahead of the APEC meeting to be held on November 10.
November 2, 2017: Media reports from the secret TPP–11 meeting held in Japan this week show that there is still no agreement between the 11 governments about the possible content of the TPP agreement without the US. They were aiming to reach agreement before a TPP -11 Ministers’ meeting on November 8-9, ahead of the APEC meeting in Vietnam on November 10.
November 2, 2017: A new research paper, co-authored by public health experts Deborah Gleeson, Joel Lexchin, Ruth Lopert and Burcu Kilic, explains the impact that the intellectual property chapter of the original Trans-Pacific Partnership could have on access to medicines in each of the TPP countries. As the TPP-11 meet this week to attempt to revive the TPP without the US, the research findings show how damaging the original medicine proposals would be.
October 31, 2017: Yesterday the Association of Salaried Medical Specialists (ASMS) in New Zealand urged the newly elected NZ Labour Coalition Government not to support extending medicine monopolies under the TPP Agreement.
October 24, 2017: An economic modelling study by the US Peterson Institute has admitted that the TPP without the US would have even less of the tiny economic benefits predicted for Australia with US participation.
October 23, 2017: New Zealand Prime Minister-elect, Labour’s Jacinda Ardern, has said that walking away from the TPP-11 talks is ‘not necessary’, although she will push to secure a ban on foreign property speculators. This would mean a change to New Zealand’s investment schedule in the TPP-11 text.